Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose

NCT07422285 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants
Pharmacokinetics

Interventions

DRUG: Evolocumab Drug Substance A
DRUG: Evolocumab Drug Substance B

Sponsor

Amgen